Diabetes mellitus
and hypertension are known to increase markers of inflammation, ie, highly
sensitive C-reactive protein [(hs)CRP], especially when they develop
microalbuminuria.
A total of 70
patients (37 males and 33 females), all having diabetes mellitus, according to
ADA criteria and micro-albuminuria in morning spot urine sample were
recruited in the study. They were randomised into 2 groups. Group A
comprised hypertensive (34 patients) and Group B (36 patients) normotensive
individuals.
(hs)CRP level was
assessed in all patients by routine assay. (hs)CRP value of >3 mg/L was
observed in 28.57% patients of group A and 12.86% patients of group B
(p=0.004).

